Cytokinetic failure and asynchronous nuclear division in BHK cells overexpressing a truncated protein-tyrosine-phosphatase by Cool,  D. E. et al.
Proc. Nati. Acad. Sci. USA
Vol. 89, pp. 5422-5426, June 1992
Cell Biology
Cytokinetic failure and asynchronous nuclear division in BHK cells
overexpressing a truncated protein-tyrosine-phosphatase
(cell cycle/cytokinesis/syncytia/mitosis)
D. E. COOL*t, P. R. ANDREASSEN*t§, N. K. TONKS¶, E. G. KREBSII, E. H. FISCHER*, AND R. L. MARGOLIS*§
Departments of *Biochemistry, *Pathology, and IIPharmacology, University of Washington, Seattle, WA 98195; and lCold Spring Harbor Laboratory, Cold
Spring Harbor, NY 11724
Contributed by E. H. Fischer, February 28, 1992
ABSTRACT Previous work has shown that a T-cell protein-
tyrosine-phosphatase truncated in its carboxyl-terminal domain
(AC11.PTP) has full enzymatic activity but no longer localizes
in the particulate fraction of the cell. Two baby hamster kidney
(BHK) cell lines overexpressing the truncated protein are
markedly multinucleate, a state likely caused by a failure in
cytokinesis. Nuclei within syncytial cells overexpressing
AC11.PTP display a remarkable asynchronous entry into
mitosis. The effects require tyrosine phosphatase activity be-
cause expression of an inactive form of the truncated enzyme
yields cells indistinguishable from the parental cell line. Re-
distribution of the enzyme from the particulate to the soluble
fraction is apparently important to these observed effects
because cells overexpressing the full-length, wild-type enzyme
are morphologically similar to controls. Further, when these
cells contain more than one nucleus, their syncytial nuclei
undergo mitosis synchronously.
Protein-tyrosine-phosphatases (PTPs) represent a diverse
family of enzymes entirely specific toward phosphotyrosyl
residues. Both transmembrane, receptor-like PTPs and in-
tracellular forms have been identified, and their primary
structures have been determined mostly from cDNA se-
quence analyses (for reviews, see refs. 1-3). Little is known
as to their precise roles in cell physiology, although the
leukocyte common antigen CD45, a hematopoietic-specific
180- to 220-kDa receptor, was shown to be essential for
coupling the T-cell receptor to the phosphatidylinositol-
turnover pathway (4). CD45 is also required for in vivo
tyrosine phosphorylation after T-cell activation (5).
The intracellular PTPs, varying from 40 to 120 kDa, that
have been identified contain large regulatory regions extend-
ing from the catalytic core toward either the amino- or
carboxyl-terminal ends of the molecule. A 48-kDa human
T-cell enzyme (TC.PTP) displays a carboxyl-terminal exten-
sion of -11 kDa that is responsible for its localization (6) and
determines its specificity toward certain artificial substrates
(7). Thus, the full-length TC.PTP localizes mainly in the
particulate fraction when expressed in baby hamster kidney
(BHK) cells and requires limited proteolysis for in vitro
activity toward reduced, carboxamidomethylated, and ma-
leylated lysozyme (7). By contrast, a 37-kDa carboxyl-
terminal-truncated form of TC.PTP (designated AC11.PTP)
localizes in the aqueous phase and is constitutively active
toward most substrates in vitro (7).
In this study we report that while BHK cells overexpress-
ing the wild-type TC.PTP exhibit a normal phenotype in
terms ofgrowth and morphology, clonal cell lines expressing
the carboxyl-terminal truncated enzyme become highly
multinucleate, apparently through a failure in cytokinesis.
The data show that cytokinesis often fails in AC11.PTP-
containing cells because furrowing cannot be completed.
Cells with syncytial nuclei exist in nature (8, 9), in certain
pathological conditions (10), and have been generated by cell
fusion (11, 12). Multinucleation can also be induced by
cytochalasin through a failure to maintain the cytokinetic
furrow (13). In all previous cases, the syncytial nuclei have
entered S-phase and mitosis synchronously, indicating that
S- and M-phase nuclei express dominant signals. Unexpect-
edly, nuclear division in syncytial BHK cells expressing
AC11.PTP occurs asynchronously. These data suggest that
tyrosine phosphorylation is involved, directly or indirectly,
in both furrow development and the signaling events that
coordinate nuclear division.
EXPERIMENTAL PROCEDURES
Mutagenesis and Expression of TC.PTP in BHK Cells.
Construction and transfection of the vector containing either
TC.PTP or ACll.PTP cDNA were as described (6). An
oligonucleotide (5'-GTGATCCACTCGAGTGCAGGCA-3')
designed to abolish catalytic activity (Cys-175 -- Ser) was
synthesized on an Applied Biosystems DNA synthesizer
(Howard Hughes Medical Institute DNA synthesis facility)
and used to prime an M13 single-stranded DNA template
containing TC.PTP cDNA (6). The methods for preparing and
isolating the mutant cDNA have been described elsewhere (6,
7). The mutation in the cDNA was verified by DNA sequence
analysis ofthe region surrounding the mutation site and found
to contain the correct point mutation as well as a premature
stop codon located 18 base pairs (bp) after Gly-327. A
1.0-kilobase-pair (kbp) Xba I fragment containing the mutant
cDNA was extracted from an agarose gel and ligated into the
expression vector as described (6).
Immunofluorescence Microscopy. Cells were grown on
polylysine-coated glass coverslips for a minimum of 12 hr,
fixed, and permeabilized as described (13). Cells prepared for
immunolocalization of proliferating cell nuclear antigen
(PCNA) were fixed according to ref. 14 by using 1% para-
formaldehyde/phosphate-buffered saline (PBS) for 2 min,
followed by -200C methanol for 10 min and treatment with
0.5% Nonidet P-40 in PBS for 2 min. Washes, incubation with
antibodies, staining with propidium iodide, and mounting of
coverslips were as described (13).
Mouse anti-a tubulin (Eastacres Biologicals, Southbridge,
MA), mouse anti-PCNA (19F4 ascites, Coulter) primary
antibodies, and anti-telophase disc serum (13) were used at
dilutions of 1:50, 1:200, and 1:500, respectively. Fluorescein
isothiocyanate-conjugated goat anti-mouse IgG and fluores-
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cein isothiocyanate-conjugated goat anti-human IgG second-
ary antibodies (Tago) were applied to cells at 8.5 Ag/ml.
Membranes were stained with an intercalating fluorescent
membrane lipid, 3,3'-dioctadecyloxacarbocyanine perchlo-
rate (DiOC18; Molecular Probes) at 100 ug/ml, directly after
fixation. Staining was done for 30 min at 37C in PBS/3%
bovine serum albumin/0.05% Tween 20/0.1% sodium azide,
followed by a PBS wash, permeabilization, and counterstain
with propidium iodide (13).
All samples were observed by using an MRC-500 laser
scanning confocal apparatus (Bio-Rad) attached to a Nikon
Optiphot microscope.
Immunoblot Analysis. Plates of BHK cells were grown to
confluency, washed three times with PBS, scraped, and
centrifuged for 3 min in a clinical centrifuge and extracted
with a 3-fold excess (vol/vol) of a low-salt buffer [25 mM
imidazole/2 mM EDTA/2 mM EGTA/8% sucrose (wt/
vol)/1 mM benzamidine/aprotinin at 50 kallikrein units per
ml/leupeptin at S Iug/ml, pH 7.0], by using a Teflon Dounce
homogenizer. The extracts were centrifuged at 100,000 X g
for 20 min at 40C. The pellets were resuspended in the same
volume of buffer but containing 0.5% Triton X-100 and 0.5 M
NaCl. The extraction procedure was then repeated, and the
supernatants were saved for immunoprecipitation. A rabbit
polyclonal anti-PTP antibody (5501) raised against purified
AC11.PT'P (7) was used for immunoprecipitation and detec-
tion in immunoblots of TC.PTP or AC11.PTP. These proce-
dures have been described elsewhere (6, 7).
Two-Dimensional Gel Analysis of Phosphotyrosine Proteins.
Nearly confluent populations of BHK cells were treated for
24 hr with 5 ,uM dihydrocytochalasin B (DCB), followed by
12 hr with nocodazole at 0.06 ,ug/ml before labeling. All cells,
including those that became detached, were collected,
washed with phosphate-free medium, and incubated for 4 hr
at 3TC in labeling medium [Dulbecco's modified Eagle's
medium/10%6 dialyzed fetal calf serum containing 1 mCi of
32p(4 (3000 Ci/mmol; 1 Ci = 37 GBq)]. Cells were rinsed
once with PBS (37°C) and frozen immediately in liquid
nitrogen. To obtain phosphotyrosine-containing proteins the
frozen cells were extracted as described in ref. 6, and 0.5 mg
of protein extract, at a concentration of 1 mg/ml, was treated
with 20 Al of anti-phosphotyrosine antibodies cross-linked to
agarose beads (Upstate Biotechnology, Lake Placid, NY).
Immunoprecipitation was done for 16 hr at 4°C with contin-
uous rotation. The beads were washed twice at 4°C with the
extraction buffer and once with 25 mM imidazole (pH 7.2)
and 1.0 mM Na3VO4. The immunoprecipitates were treated
for 2 min at 4°C with 3 jul of RNase/DNase (1 mg/ml)
followed by 3 min at 37°C in 40 ,ul of 0.3% SDS. Two-
dimensional analysis of the samples was performed on the
immunoprecipitates as described (15).
RESULTS
Multinucleation Phenotype in BHK Cells Overexpressing
ACll.PTP. Several independent lines of AC11.PTP-
transfected BHK cells are clearly distinct in morphology
from controls containing the vector alone or those overex-
pressing the 48-kDa wild-type TC.PTP. The most striking
alteration, a highly multinucleate state, was observed in two
established cell lines designated as IC6 and 3A3. Phase
contrast (data not shown) and confocal microscopy (Fig. 1)
reveals that 60% and 28% of IC6 cells and 3A3 cell lines,
respectively, contain multiple nuclei (Table 1). By contrast,
binucleate and multinucleate cells are rarely seen (<10%1) in
control cells or in cells overexpressing TC.PTP (Table 1).
To demonstrate the multinucleated state unequivocally,
cells were labeled with DiOC18, a membrane-intercalating
fluorescent lipid that marks endoplasmic reticulum and the
plasma membrane. With this stain, one can readily distin-
guish between two closely apposed cells (Fig. 1C) and cells
that contain multiple nuclei within one contiguous cytoplasm,
such as IC6 (Fig. 1A). In contrast, cells overexpressing
TC.PTP (Fig. 1B) and control cells (Fig. 1C) are largely
mononucleate.
In a control experiment, an inactive form of AC11.PTP
(CS-AC11.PTP) was transfected into BHK cells, and numer-
ous methotrexate-resistant colonies containing the mutant
were selected. As shown for one representative cell line
analyzed by confocal microscopy, the level of multinucle-
ation was indistinguishable from control cells (Table 1). Of a
total of 13 independent methotrexate-resistant colonies se-
lected, none exhibited >8% binucleate phenotype.
Defective Cytokinesis in BHK Cells Overexpressing
AC11.PTP. In normal cells during late mitosis, a telophase
disc forms at the spindle equator and completely bisects the
cell undergoing cleavage. This element contains a 60-kDa
protein, designated TD-60 (13). Antibodies to TD-60 were
used to monitor cleavage-furrow formation and progression
in ACll.PTP and control cells (Fig. 2). In the controls, the
disc coincides with the cleavage furrow throughout telophase
(Fig. 2A). By contrast, in AC11.PTP cells, the telophase disc
is seen in a variety of constricted diameters, and yet mem-
brane furrowing is either absent or incomplete (Fig. 2 B and
C), suggesting that multinucleation results from a defect in
cytokinesis.
Asynchronous Mitosis in Multinucleate AC11.PTP Cells.
Unexpectedly, the syncytial nuclei of AC11.PTP-containing
cells appear to enter mitosis asynchronously (Table 1). In one
example, a cell is shown in which a set of mitotic chromo-
somes coexists with two interphase nuclei in a contiguous
cytoplasm (Fig. 3A). When cells are optically sectioned along
the vertical Z axis by confocal microscopy, there is no
apparent boundary between the mitotic and interphase do-
mains of the cell (data not shown). All BHK cell lines
overexpressing AC11.PTP were asynchronous, regardless of
whether they exhibited a high or low level ofmultinucleation.
Conversely, those cells overexpressing the full-length en-
zyme and rendered multinucleate with DCB are completely
synchronous in mitosis (Fig. 3B).
To test whether mitotic asynchrony correlates with
AC11.PTP activity, 13 clonal lines that express the inactive
enzyme (CS-AC11.PTP) were analyzed. None of these, in-
cluding the small number of naturally occurring binucleate
cells or multinucleate cells induced by DCB treatment,
showed any asynchrony (Table 1). This result indicates that
the activity of the truncated enzyme is responsible for the
observed nuclear asynchrony.
Asynchrony also extends to the cytoplasmic domain sur-
rounding each nucleus as illustrated in Fig. 4. A single cell
contains a mitotic spindle immediately adjacent to an inter-
phase microtubule array (Fig. 4); their corresponding chro-
mosomes and nucleus are also shown (Fig. 4'). The image
represents a 0.3-,um horizontal optical section of the cell,
eliminating the possibility that this image represents one
microtubule array overlying the other.
Although, typically, AC11.PTP syncytial cells display only
one nucleus in mitosis at any one time, other nuclei in the cell
are also cycling. Nuclei at distinct stages of interphase can
coexist with mitotic chromosomes in a single cell. For
example, a cell is shown where one nucleus is in S phase, as
demonstrated by the presence ofPCNA (Fig. 5) (16, 17), and
the other is in mitosis, as is evident from the presence of
condensed chromosomes (Fig. 5'). These data suggest that
the mitotic dominant signal does not induce the premature
chromosome condensation of S-phase nuclei normally char-
acteristic of syncytial cells (11).
Subcellular Localiztion of Full-Length and Truncated PTP
May Be Responsible for Multinucleation and Asynchrony. It
has been previously shown that the overexpressed full-length
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FIG. 1. Cells overexpressing AC11.PTP cDNA become multinucleate. Multinucleation was determined by epifluorescence analysis using the
membrane marker DiOC18 (green) and the DNA stain propidium iodide (red). (A) A multinucleate AC11.PTP-containing cell is distinguished by
the presence oftwo or more nuclei (red) within a single contiguous cytoplasm (green). In contrast, cells overexpressing TC.PTP (B) or the vector
alone (C) typically exhibit only one nucleus. DiOC1s highlights the membrane barrier between two adjoining cells (C).
Fig. 2. Multinucleation results from a failure in cytokinesis. BHK AC11.PTP cells were synchronized in mitosis by release from nocodazole
blockage. After 60 min ofrecovery, cells were fixed and probed with antiserum to TD-60, which serves as a telophase marker (13). (A) The telophase
disc (green, white where intense) normally remains associated with the plasma membrane throughout furrowing and becomes increasingly constricted.
In AC11.PTP cells, the disc is frequently seen as either partially (B) or fully (C) constricted but disjoined from the plasma membrane, which exhibits
little or no furrowing. Cells are counterstained with propidium iodide (red or orange). The cell border is made evident by TD-60 background (green).
Fig. 3. Asynchronous entry ofAC11.PTP syncytial nuclei into mitosis. (A) Multinucleated AC11.PTP cells generally enter mitosis asynchronously,
as demonstrated by prophase chromosomes (red) and two interphase nuclei (red) within the same cytoplasm stained with DiOC18 (green). Cells were
blocked 16 hr in nocodazole at 0.06 ,ug/ml and released for 60 min before fixation and staining. (B) Multinucleate cells expressing the full-length PTP
and containing two to four nuclei after 5 AM DCB treatment enter mitosis synchronously. One cell with three sets of condensed chromosomes and
two binucleate cells are shown. Multinucleate TC.PTP cells were generated by 24- to 48-hr blockage with 5 AM DCB and were further treated with
nocodazole at 0.06 ,ug/ml for the last 12 hr.
Fig. 4. Asynchrony ofmicrotubules in cytoplasmic domains ofAC11.PTP cells. A mitotic spindle and an interphase microtubule array (both green)
detected with anti-tubulin antibody are found in the same cell, indicating cytoplasmic compartmentalization of the cytoskeleton (Fig. 4). Double
labeling with propidium iodide shows both mitotic and interphase chromatin (Fig. 4'). The image represents a 0.3-,m section.
Fig. 5. S-phase and mitotic nuclei coexist within syncytial AC11.PTP cells. A AC11.T cell with one mitotic and one interphase nucleus
is shown. (Fig. 5) The interphase nucleus is in S phase, as determined by staining for PCNA (green) (16, 17). (Fig. 5') Staining with propidium iodide
(red) illustrates juxtaposition of the mitotic chromosomes and the nucleus. Cells were blocked with nocodazole at 0.06 ,g/ml for 12-16 hr before
immunofluorescent staining.
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Table 1. Asynchronous nuclear division of multinucleated cells
containing the truncated T-cell PTP
Cells Bi/multinucleated
with two or more cells with
nuclei, % asynchronous nuclei, %
/&C11.PTP
IC6 61.0 + 2.9 80.8
3A3 28.4 + 1.9 *
TC.PTP 9.6 + 3.0 O.Ot
Control (vector only) 7.9 + 2.2 O.Ot
CSAC11.PTP 7.5 + 2.0 O.Ot
Cells expressing the truncated T-cell PTP (AC11.PTP) are pre-
dominantly multinucleate; although most ofthese cells have 2 nuclei,
cells with 3-10 nuclei are common (data not shown). In contrast,
multinucleation is a low-frequency event in cells overexpressing the
full-length T-cell PTP cDNA (TC.PTP) or the vector alone. Most
multinucleated AC11.PTP cells have asynchronous nuclei, so that
condensed chromosomes occur in the same cytoplasm with inter-
phase nuclei. For each cell type, three counts of 100 cells were made
by epifluorescence of propidium iodide-stained nuclei. Continuity of
cytoplasm was established by staining cytoplasmic RNA with pro-
pidium iodide and by phase-contrast microscopy (data not shown).
*Asynchrony is present but has not been statistically determined.
tAsynchrony was quantitated for populations in which multinucle-
ation was induced by 48-hr treatment with 5 ,uM DCB.
TC.PTP and AC11.PTP distribute primarily to the particulate
and soluble fractions of BHK cells, respectively, as deter-
mined by their activities (6). We have further examined the
intracellular localization of these enzymes by immunoblot
analyses. Extracts from the soluble and particulate fractions
were immunoprecipitated with a polyclonal antibody raised
against purified AC11.PTP (7) and probed with the same
antibody (Fig. 6). Both AC11.PTP and CSAC11.PTP were
readily extracted in the aqueous phase with low-salt buffers,
whereas almost all of the TC.PTP was particulate (Fig. 6).
The data indicate that the phenotype of enhanced multinu-
cleation and asynchronous nuclear division correlates with
the localization of PTP activity within the soluble cytoplas-
mic fraction.
Tyrosine Phosphorylation in PTP-Overexpressing Cells. An-
ti-phosphotyrosine immunoprecipitates from extracts of
1.ro& -f AC
$4 .
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FIG. 6. Expression and compartmentalization ofPTP in different
BHK cell lines. Soluble and particulate fractions were obtained by a
low-salt cell extraction followed by high-speed centrifugation and
solubilization of the pellet in a high-salt/detergent buffer. PTP was
immunoprecipitated with anti-PTP (5501) from these extracts, after
adjustment to equivalent protein concentrations, and subjected to
immunoblot analysis. Blots were probed by using the same PTP
antibody and 1251-labeled protein A. Extracts from cells expressing
the vector alone (lane C), full-length TC.PTP, active-truncated
AC11.PTP (lane ACil), or inactive-truncated CS-AC11.PTP were
analyzed. The molecular masses of the proteins were determined
from prestained markers (Amersham). CS-AC11.PTP encodes an
inactive 40-kDa carboxyl-terminal truncated species recognized by
antibody 5501. The slightly higher molecular mass of this species
results from the addition of six amino acid residues, bearing no
sequence homology to PTPs, at its carboxyl-terminal end (after
Gly-327).
BHK cells 32P-labeled in vivo were analyzed by two-
dimensional gel electrophoresis (Fig. 7). The cells were
treated with DCB to generate uniformly multinucleate pop-
ulations and with nocodazole to arrest cells at mitosis. Fig. 7
shows that the level of tyrosine phosphorylation of several
proteins either increases or decreases relative to controls
(closed and open arrows, respectively), depending on
whether the full-length or truncated PTP is being expressed.
* *
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FIG. 7. Two-dimensional gel analysis of 32P-labeled phosphotyrosyl proteins immunoprecipitated from BHK cells. Cells were labeled for
4 hr with 32p1; total extracts, equalized for protein concentrations, were immunoprecipitated by using an anti-phosphotyrosine antibody.
Precipitated proteins were separated by isoelectric focusing (pH 3-10) in the first dimension followed by a 10%o Laemmli gel for the second
dimension. The gels were dried and exposed to film for 7 days at -70°C with DuPont intensifier screens. Immunoprecipitated proteins from
cells containing vector control (V); active, truncated AC11.PTP (AC), and full-length TC.PTP (TC) are shown. Open or closed arrows indicate
those proteins with reduced or enhanced level of phosphorylation, respectively, compared with controls. Molecular sizes of standard proteins
are shown. The possibility that 32P-labeled serine/threonine-containing proteins coprecipitated with proteins phosphorylated on tyrosine cannot
be excluded.
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DISCUSSION
This study indicates that loss of the carboxyl-terminal seg-
ment ofTC.PTP results in a form of cellular anarchy in which
the enzyme, no longer restricted to specific compartments or
subjected to modulation by regulatory molecules, acquires
the capability of dephosphorylating previously inaccessible
substrates. This, in turn, has profound consequences with
respect to cytokinesis and cell-cycle regulation. Cytokinesis
seems to fail in these clonal cell lines due to their inability to
sustain furrow progression to completion. Although cytoki-
nesis is an actomyosin-dependent process (18-20), there is no
indication that the AC11.PTP acts on actin itself because it
does not induce disassembly of interphase actin cables (un-
published observations). However, AC11.PTP might affect
the phosphotyrosyl level ofproteins that directly or indirectly
interact with actin or with components of the telophase disc
that align with the cytokinetic furrow (13).
A surprising observation is that all multinucleated
AC11.PTP cell lines exhibit a striking asynchrony in mitosis:
interphase and mitotic nuclei with their corresponding mi-
crotubule arrays coexist in distinct domains within the syn-
cytial cell. Under normal conditions, the onset of mitosis
occurs simultaneously in various compartments of the cell,
including the nucleus and the cytoplasm. Specific signals
must coordinate this event, initiated by factors such as
p34cdc2, a protein kinase required for both Gl/S (21, 22) and
G2/M transitions (23-25) in mammalian cells. p34cdc2 is
partially localized to the centrosome during late G2 (23, 26);
therefore, the possibility exists that the centrosome acts to
control mitotic entry of the proximal nucleus. Induction of
mitosis would, thus, appear to involve domains of the cell,
centered on individual nuclei, acting as independent and
integrated units.
p34cdc2 is activated by tyrosine dephosphorylation during
the G2/M transition (27-29); in Saccharomyces pombe, the
reaction is brought about by p80cdc25 (30-32). A ts-p80cdc25-22
mutant fails to divide at the restrictive temperature but is
rescued by overexpression of TC.PTP (33), indicating a role
for tyrosine phosphatases in cell-cycle regulation. Cell-cycle
signals are disrupted in BHK cells containing the truncated
PTP but are not disrupted in those cells overexpressing the
full-length enzyme or the inactive truncated mutant. This
result suggests that the aberrant behavior is due to the
localization of the truncated enzyme and its access to inap-
propriate substrates. As of yet, no identification has been
made ofthose target proteins that might be responsible for the
regulation of cytokinesis and of cell-cycle synchrony.
In cells expressing either the 48- or 37-kDa PTP, phos-
phorylation of a few substrates appears to be diminished or
enhanced. Increased phosphorylation may be from the acti-
vation of a src-family tyrosine kinase by dephosphorylation
of a tyrosyl residue at the carboxyl terminus (34, 35). Such a
mechanism has been proposed for the CD45 activation of the
lymphocyte-specific p561ck (36, 37).
The data suggest that changes in tyrosine phosphorylation
regulate the activity of factors that synchronize the behavior
of individual nuclei and their surrounding cytoplasm within
discrete units in the syncytial cell. It is possible that these
events are controlled by the centrosomes. It would, then, be
of considerable interest to determine how a soluble PTP
could generate a local signal at a single centrosome capable
of initiating mitosis only within that particular domain.
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